Bgm (BGM) Current Deferred Revenue (2019 - 2025)
Bgm (BGM) posted quarterly Current Deferred Revenue of $3.1 million for Q3 2025, up 541.61% year-over-year from $489784.0 in Q3 2024, and up 2516.3% quarter-over-quarter from $120113.0 in Q1 2025.
Bgm (BGM) Current Deferred Revenue (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Current Deferred Revenue for 7 consecutive years, with $3.1 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Current Deferred Revenue rose 541.61% year-over-year to $3.1 million; the TTM figure through Sep 2025 stood at $3.1 million (up 541.61% YoY), while the FY2025 annual figure was $3.1 million, up 541.61% from the prior year.
- Current Deferred Revenue advanced to $3.1 million in Q3 2025 per BGM's latest filing, from $120113.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $245.9 billion in Q1 2022 and bottomed at $77608.0 in Q1 2024.
- Historically, Current Deferred Revenue has averaged $36.4 billion across 5 years, with a median of $1.0 million in 2023.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue plunged 100.0% — and 2025, when it surged 541.61%.
- Bgm's Current Deferred Revenue stood at $2.5 million in 2021, then tumbled by 77.45% to $556418.0 in 2022, then jumped by 84.81% to $1.0 million in 2023, then plunged by 52.37% to $489784.0 in 2024, then soared by 541.61% to $3.1 million in 2025.
- Business Quant data shows BGM's Current Deferred Revenue at $3.1 million in Q3 2025, $120113.0 in Q1 2025, and $489784.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Bgm | 30.61 Mn | 20.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.14 Mn |
| Mar 31, 2025 | 120,113.00 |
| Sep 30, 2024 | 489,784.00 |
| Mar 31, 2024 | 77,608.00 |
| Sep 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 81.60 Bn |
| Sep 30, 2022 | 556,418.00 |
| Mar 31, 2022 | 245.87 Bn |
| Sep 30, 2021 | 2.47 Mn |
| Sep 30, 2020 | 3.51 Mn |
| Sep 30, 2019 | 1.91 Mn |